Search results
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 13 hours agoOther times, some corporations lag the market for good reasons: Their businesses and prospects look...
Novavax, Inc. (NVAX) vs. Its Peers: A Comparison – News Heater
NewsHeater· 7 days agoThere are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.” The public float for NVAX is 132.98M ...
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks via Yahoo Finance· 9 hours agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
The path to a better tuberculosis vaccine runs through Montana
Medical Xpress· 8 hours agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
InvestorPlace· 5 days agoIf you have a high tolerance for volatility then the biotech sector might be for you. Biotech stocks...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 5 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Europe Strengthens Future Disease Defense
Medscape· 4 days agoA network of health security agencies has been established in Europe and Central Asia to bolster the region's preparedness to meet future disease...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 6 days agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...